Kazia Therapeutics Statistics
Total Valuation
KZIA has a market cap or net worth of $9.34 million. The enterprise value is $9.26 million.
| Market Cap | 9.34M |
| Enterprise Value | 9.26M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KZIA has 23.63 million shares outstanding.
| Shares Outstanding | 23.63M |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 18.54% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 596.54 |
| Forward PS | n/a |
| PB Ratio | 2.73 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 591.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of 0.66.
| Current Ratio | 0.71 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -186.40% and return on invested capital (ROIC) is -222.13%.
| Return on Equity (ROE) | -186.40% |
| Return on Assets (ROA) | -60.10% |
| Return on Capital (ROIC) | -222.13% |
| Revenue Per Employee | $1,739 |
| Profits Per Employee | -$1.19M |
| Employee Count | 9 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -175,798 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.17% in the last 52 weeks. The beta is 2.11, so KZIA's price volatility has been higher than the market average.
| Beta (1Y) | 2.11 |
| 52-Week Price Change | -71.17% |
| 50-Day Moving Average | 0.30 |
| 200-Day Moving Average | 0.60 |
| Relative Strength Index (RSI) | 60.26 |
| Average Volume (30 Days) | 908,261 |
Short Selling Information
| Short Interest | 259,530 |
| Short Previous Month | 242,790 |
| Short % of Shares Out | 0.12% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.41 |
Income Statement
In the last 12 months, KZIA had revenue of $15,650 and -$10.68 million in losses. Loss per share was -$0.36.
| Revenue | 15,650 |
| Gross Profit | 14,923 |
| Operating Income | -12.57M |
| Pretax Income | -10.36M |
| Net Income | -10.68M |
| EBITDA | n/a |
| EBIT | -10.36M |
| Loss Per Share | -$0.36 |
Balance Sheet
The company has $2.31 million in cash and $2.24 million in debt, giving a net cash position of $71,122 or $0.00 per share.
| Cash & Cash Equivalents | 2.31M |
| Total Debt | 2.24M |
| Net Cash | 71,122 |
| Net Cash Per Share | $0.00 |
| Equity / Book Value | 3.42M |
| Book Value Per Share | 0.14 |
| Working Capital | -2.16M |
Cash Flow
| Operating Cash Flow | -8.23M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.23M |
| FCF Per Share | -$0.36 |
Margins
Gross margin is 95.36%, with operating and profit margins of -80,293.36% and -68,255.35%.
| Gross Margin | 95.36% |
| Operating Margin | -80,293.36% |
| Pretax Margin | -66,210.85% |
| Profit Margin | -68,255.35% |
| EBITDA Margin | n/a |
| EBIT Margin | -66,210.85% |
| FCF Margin | -52,578.78% |
Dividends & Yields
KZIA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -72.73% |
| Shareholder Yield | -72.73% |
| Earnings Yield | -114.42% |
| FCF Yield | -88.14% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 14, 2017. It was a reverse split with a ratio of 1:4.
| Last Split Date | Jul 14, 2017 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
KZIA has an Altman Z-Score of -7.49 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.49 |
| Piotroski F-Score | 1 |